Goshen, INNCT07259317Now EnrollingIRB Ready

Adenocarcinoma Clinical Trial in Goshen, IN

Access cutting-edge adenocarcinoma treatment through this clinical trial at a research site in Goshen. Study-provided care at no cost to qualified participants.

Sponsored by Corcept Therapeutics

Quick Self-Assessment

See if you qualify for this Goshen location

Preparing your pre-screening questions…

Expert Care in Goshen

Access adenocarcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related adenocarcinoma treatment provided free

Apply for This Goshen Location

Check if you qualify for this adenocarcinoma clinical trial in Goshen, IN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Goshen

    Convenient for IN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Goshen site if eligible
  4. 4Begin participation

About This Adenocarcinoma Study in Goshen

This is a 2-part, Phase 2 study to evaluate the safety, tolerability, dosing, pharmacokinetics (PK), and efficacy of relacorilant in combination with nab-paclitaxel and gemcitabine in chemotherapy-naïve patients with metastatic pancreatic adenocarcinoma (PDAC).

Sponsor: Corcept Therapeutics

Who Can Participate

Inclusion Criteria

Signed and dated informed consent form prior to screening procedures
Histologic diagnosis or cytologic diagnosis of pancreatic adenocarcinoma (PDAC)
Initial diagnosis of metastatic disease occurred ≤9 weeks prior to enrollment in the study
Life expectancy of ≥3 months
Radiographic confirmation of metastatic disease with at least 1 distant tumor metastasis measurable on radiology imaging per RECIST version 1.1 criteria
Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
Able to provide informed consent and comply with protocol requirements
Able to swallow and retain oral medication and does not have uncontrolled emesis
Has adequate gastrointestinal absorption
Received no prior systemic anticancer chemotherapy to treat metastatic PDAC. Treatment of PDAC with a single agent RAS inhibitor is permitted.
If a patient received prior treatment of PDAC with chemotherapy, disease progression must have occurred \>12 months after completing the last dose, and no persistent treatment-related toxicities can be present.
Adequate organ function
Negative pregnancy test for patients of childbearing potential
Agree to use protocol defined precautions to avoid pregnancy

Exclusion Criteria

Any major surgery within 4 weeks prior to enrollment
Prior treatment as follows:
Radiotherapy, surgery, chemotherapy, immunotherapy, investigational therapy for the treatment of metastatic disease
Systemic, inhaled, or prescription strength topical corticosteroids within 5 times the half-life of the corticosteroid used prior to first dose of study drug
Received gemcitabine or nab-paclitaxel to treat their PDAC
Known germline or somatic breast cancer gene (BRCA) mutation
Peripheral neuropathy from any cause \>Grade 1
Medical conditions requiring chronic or frequent treatment with corticosteroids
History of severe hypersensitivity or severe reaction to any of study drugs or their excipients
Concurrent treatment with mifepristone or other glucocorticoid receptor modulators.
Uncontrolled condition(s) which, may confound the results of the trial or interfere with the patient's safety or participation
Active infection with HIV, hepatitis C or hepatitis B virus
Known untreated parenchymal brain metastasis or uncontrolled central nervous system metastases
History of other malignancy within 3 years prior to enrollment
Taking protocol-prohibited medications
Concurrent treatment with other investigational treatment studies for cancer
Has received a live vaccine within 30 days prior to the study start date

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Goshen?

Yes, this clinical trial (NCT07259317) has an active research site in Goshen, IN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Adenocarcinoma Treatment Options in Goshen, IN

If you're searching for adenocarcinoma treatment options in Goshen, IN, this clinical trial (NCT07259317) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Goshen research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adenocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all adenocarcinoma clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Goshen, IN

See all lung cancer clinical trials recruiting in Goshen — not just this study.

Browse Lung Cancer Trials in Goshen →

Browse More Trials by Condition

Lung Cancer TrialsProstate Cancer TrialsPancreatic Cancer TrialsStomach Cancer TrialsEsophageal Cancer TrialsNon-Small Cell Lung Cancer TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Goshen?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Goshen, IN